Market Research Logo

Global Markets for Allergy Diagnostics and Treatments

Global Markets for Allergy Diagnostics and Treatments


Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.

This report provides:

An overview of the global markets for allergy diagnostics and treatments.

Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.

Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.

Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.

Profiles of major players in the allergy diagnostics and treatments industry.


SCOPE OF REPORT

This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).

The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market. The report organizes information from diverse sources into a cohesive unit that includes:
A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.

Prescription and over-the-counter (OTC) medications are further broken down into specific types of administration. Each subsegment is covered in depth with regard to oral, spray, topical, and ocular applications; current treatments, market size, and market participants; potential research and development; and forecasted market size and growth.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
METHODOLOGY AND INFORMATION SOURCES
INTENDED AUDIENCE
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
ALLERGY TYPES
PROJECTED GLOBAL MARKET
GLOBAL ALLERGY DIAGNOSTIC MARKET
GLOBAL IMMUNOTHERAPY MARKET
GLOBAL ALLERGY MEDICATION MARKET
REGIONAL DIAGNOSTIC, IMMUNOTHERAPY, AND TREATMENT MARKET LEADERS
DIAGNOSTIC MARKET
IMMUNOTHERAPY MARKET
TREATMENT MARKET
SUMMARY TABLE GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKETS BY TYPE, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY REGION, 2015 AND 2020 (%)
CHAPTER 3 OVERVIEW OF ALLERGIES
DEFINITION OF ALLERGIES
ALLERGIES AND ASTHMA
ALLERGIES AND CLIMATE CHANGE
TYPES OF ALLERGIC REACTIONS
ENVIRONMENTAL ALLERGIES
Allergic Rhinitis
Rhinosinusitis
FOOD ALLERGIES
TABLE 1 MOST COMMON FOOD ALLERGIES IN THE U.S. AND EUROPE
Can Food Allergies be Outgrown?
Diagnosing Food Allergies
TABLE 2 FOOD ALLERGENS (IN ORDER OF DECREASING PREVALENCE)
IN VARIOUS COUNTRIES
TABLE 3 TESTS FOR FOOD ALLERGIES
LATEX ALLERGIES
Diagnosis and Treatment of Latex Allergies
INSECT ALLERGIES
Diagnosis and Treatment
SKIN ALLERGIES
Atopic Eczema
Urticaria
TABLE 4 POTENTIAL TRIGGERS FOR HIVES
Angioedema
EYE ALLERGIES
Allergic Conjunctivitis
ALLERGIES TO DRUGS AND BIOLOGICAL AGENTS
ALLERGY TESTING MANUFACTURERS
TABLE 5 ALLERGY TESTING MANUFACTURERS BY COMPANY AND LOCATION FIGURE 1 ALLERGY DIAGNOSTIC MANUFACTURER MARKET BY COUNTRY, 2014 (%)
IMMUNOTHERAPY PRODUCTS AND MANUFACTURERS
TABLE 6 ALLERGY IMMUNOTHERAPY MANUFACTURERS BY COMPANY AND TYPE OF PRODUCT
ALLERGY MEDICATION MANUFACTURERS
TABLE 7 ALLERGY MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, FORMULATION, AND INDICATION FOR USE OF PRODUCT
TOPICAL STEROID TREATMENTS
TABLE 8 TOPICAL STEROID MEDICATION MANUFACTURERS BY POTENCY, COMPANY, PRODUCT NAME, AND FORMULATION
ANAPHYLAXIS TREATMENTS
TABLE 9 ANAPHYLAXIS MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, FORMULATION, AND INDICATION FOR USE OF PRODUCT
ALLERGIC CONJUNCTIVITIS TREATMENTS
TABLE 10 ALLERGIC CONJUNCTIVITIS MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, AND FORMULATION
GENERIC ALLERGY TREATMENTS
TABLE 11 GENERIC ALLERGY MEDICATION MANUFACTURERS BY TYPE, PRODUCT NAME, FORMULATION, AND INDICATION
MERGERS AND ACQUISITIONS IN THE ALLERGY MARKET
TABLE 12 SELECTED MERGERS AND ACQUISITIONS PERTINENT TO THE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2009-2014
CHAPTER 4 GLOBAL ALLERGY DIAGNOSTICS MARKET
PROJECTED MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS
TABLE 13 PROJECTED GLOBAL MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 2 PROJECTED GLOBAL MARKET FOR ALLERGY DIAGNOSTIC TESTING PRODUCTS BY TYPE, 2015 AND 2020 (%)
TYPES OF DIAGNOSTIC TESTS
SKIN TESTING
PROVOCATION TESTING
BLOOD ANALYSIS
Design of an Enzyme Immunoassay
BLOOD TESTING
Advantages and Disadvantages of Blood Testing
TABLE 14 APPROPRIATE TESTING FOR ALLERGIES BY TYPE OF ALLERGY AND TEST
REGIONAL MARKETPLACES
TABLE 15 PROJECTED REGIONAL MARKETS FOR ALLERGY DIAGNOSTIC PRODUCTS, THROUGH 2020 ($ MILLIONS)
FIGURE 3 PROJECTED REGIONAL MARKETS FOR ALLERGY DIAGNOSTIC PRODUCTS, 2015 AND 2020 (%)
PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTICS
TABLE 16 PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
FIGURE 4 PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
AMERICAS' ALLERGY DIAGNOSTIC MARKET BY REGION
U.S.
CANADA
CENTRAL AND SOUTH AMERICA
TABLE 17 PROJECTED AMERICAS' MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 5 PROJECTED AMERICAS' MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTICS
TABLE 18 PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
FIGURE 6 PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
EMRA'S ALLERGY DIAGNOSTIC MARKET BY REGION
EUROPE
MIDDLE EAST
AFRICA
PROJECTED EMRA ALLERGY DIAGNOSTIC MARKET
TABLE 19 PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 7 PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020
PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTICS
TABLE 20 PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
FIGURE 8 PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
ASIAN ALLERGY DIAGNOSTIC MARKET BY REGION
TABLE 21 COMPARATIVE POPULATION PREVALENCE OF DIAGNOSED NASAL ALLERGIES (%)
ALLERGIC TRIGGERS IN ASIAN REGION
JAPAN
CHINA
FIGURE 9 DIAGNOSIS FOR ALLERGIC RHINITIS IN CHINA (%)
INDIA
PROJECTED ASIAN ALLERGY DIAGNOSTIC MARKET
TABLE 22 PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 10 PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
CHAPTER 5 GLOBAL IMMUNOTHERAPY MARKET
TABLE 23 PROJECTED GLOBAL MARKET FOR IMMUNOTHERAPY ALLERGY PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
FIGURE 11 PROJECTED GLOBAL MARKET FOR IMMUNOTHERAPY ALLERGY PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
SLIT ADMINISTRATION APPROACH
IMMUNOLOGIC CHANGES FOLLOWING SLIT
COMPARISON OF SUBCUTANEOUS IMMUNOTHERAPY AND SUBLINGUAL
IMMUNOTHERAPY
SINGLE ANTIGEN VERSUS MULTI-ANTIGEN THERAPY
IMMUNOTHERAPY PRODUCTS
TABLE 24 ALLERGEN SUBLINGUAL AND INJECTABLE ALLERGEN EXTRACT
IMMUNOTHERAPY TREATMENTS
IMMUNOTHERAPY MARKET PARTICIPANTS
FIGURE 12 MARKET ANALYSIS FOR IMMUNOTHERAPY PRODUCTS BY PARTICIPANT, 2012 (%)
REGIONAL MARKETS
TABLE 25 PROJECTED REGIONAL MARKETS FOR IMMUNOTHERAPY PRODUCTS, THROUGH 2020 ($ MILLIONS)
FIGURE 13 PROJECTED REGIONAL MARKETS FOR IMMUNOTHERAPY PRODUCTS, 2015 AND 2020 (%)
AMERICAS
TABLE 26 PROJECTED AMERICAS MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 14 PROJECTED AMERICAS MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
U.S.
Brazil
EMRA
TABLE 27 PROJECTED EMRA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 15 PROJECTED EMRA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
Western Europe
Middle East
ASIA
TABLE 28 PROJECTED ASIA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 16 PROJECTED ASIA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
Japan
China
CHAPTER 6 GLOBAL ALLERGY TREATMENT MARKET
GLOBAL MARKET FOR ALLERGY PRODUCTS
TABLE 29 PROJECTED GLOBAL MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
FIGURE 17 PROJECTED GLOBAL MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
PRESCRIPTION ALLERGY PRODUCTS
TABLE 30 PROJECTED GLOBAL MARKET FOR PRESCRIPTION ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
GENERIC ALLERGY PRODUCTS
MARKET DRIVERS
GLOBAL GENERIC ALLERGY MARKET
TABLE 31 PROJECTED GLOBAL MARKET FOR GENERIC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
FIGURE 18 PROJECTED GLOBAL MARKET FOR GENERIC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
GENERIC INDUSTRY IN THE U.S.
OTC ALLERGY PRODUCTS
TABLE 32 PROJECTED GLOBAL MARKET FOR OTC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
FIGURE 19 PROJECTED GLOBAL MARKET FOR OTC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
TYPES OF ALLERGY MEDICATIONS
TABLE 33 PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 20 PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, 2015 AND 2020 (%)
ANTIHISTAMINES AND ANTIHISTAMINE COMBINATIONS
Benefits/Disadvantages
Antihistamine Products
TABLE 34 ANTIHISTAMINE AND ANTIHISTAMINE COMBINATION PRODUCTS, 2014
Market Size for Antihistamines and Antihistamine Combinations
TABLE 35 PROJECTED GLOBAL MARKET FOR ANTIHISTAMINE AND ANTIHISTAMINE COMBINATIONS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
FIGURE 21 PROJECTED GLOBAL MARKET FOR ANTIHISTAMINE AND ANTIHISTAMINE COMBINATIONS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS
Overview
Benefits/Disadvantages
TABLE 36 AVAILABLE SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS BY NAME AND MANUFACTURER, 2014
Sympathomimetics, Decongestants and Combinations Market Size
TABLE 37 PROJECTED GLOBAL MARKET FOR SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
CORTICOSTEROID ALLERGY PRODUCTS
Overview
Benefits/Disadvantages
TABLE 38 CORTICOSTEROID PREPARATIONS BY NAME AND MANUFACTURER
Corticosteroid Market Size
TABLE 39 PROJECTED GLOBAL MARKET FOR ALLERGY
CORTICOSTEROIDS BY FORM OF ADMINISTRATION,
THROUGH 2020 ($ MILLIONS)
MAST CELL STABILIZERS
Overview
TABLE 40 PROJECTED GLOBAL MARKET FOR ALLERGY MAST CELL STABILIZERS BY FORM OF ADMINISTRATION, THROUGH 2020 ($MILLIONS)
TABLE 41 SELECTED MAST CELL STABILIZER ALLERGY PRODUCTS BY NAME AND MANUFACTURER
LEUKOTRIENE RECEPTORS
TABLE 42 PROJECTED GLOBAL MARKET FOR LEUKOTRIENE RECEPTOR TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
ANAPHYLAXIS TREATMENT
TABLE 43 PROJECTED GLOBAL MARKET FOR ANAPHYLAXIS TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
REGIONAL MARKETS FOR ALLERGY TREATMENTS
TABLE 44 PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 22 PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION, 2015 AND 2020 (%)
ALLERGY TREATMENT IN THE AMERICAS
U.S. ALLERGY TREATMENT MARKET
Treatment Costs
TABLE 45 ESTIMATED COSTS FOR TREATING ALLERGIES IN THE U.S., 2012 ($ BILLIONS)
Allergic Reactions
FIGURE 23 ALLERGY DEMOGRAPHICS BY TYPE OR CAUSE, 2012 (%)
Allergy Population in the U.S.
Regional Variations
TABLE 46 WORST U.S. CITIES FOR ALLERGIES BY ALLERGEN, 2011
Sensitization by Gender
Sensitization by Age
FIGURE 24 PROJECTED PERCENTAGE OF U.S. POPULATION WITH AND WITHOUT ALLERGIES, 2015 AND 2020 (%)
ALLERGY RATES BY REGION
FIGURE 25 REGIONS/COUNTRIES WITHIN THE AMERICAS WITH HIGHEST CONCENTRATIONS OF DIAGNOSED ALLERGY CASES, 2013 (%)
AMERICAS ALLERGY TREATMENT MARKET
TABLE 47 PROJECTED AMERICAS MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
FIGURE 26 PROJECTED AMERICAS MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
TABLE 48 PROJECTED AMERICAS MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
ALLERGY TREATMENT PRODUCTS BY REGION
TABLE 49 PROJECTED AMERICAS MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
South and Central American Treatment Market
ALLERGY TREATMENT IN THE EMRA
ALLERGIES IN EUROPE
PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC
ALLERGY PRODUCTS
TABLE 50 PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($MILLIONS)
FIGURE 27 PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
TABLE 51 PROJECTED EMRA MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
RUSSIA
TABLE 52 PROJECTED EMRA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
ALLERGY TREATMENT IN ASIA
TABLE 53 PROJECTED ASIA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
JAPAN
CHINA
Treatment Satisfaction in China
INDIA
TABLE 54 MEDICATIONS FOR ALLERGY TREATMENT IN INDIA BY NAME, TYPE AND CONDITION, 2014
AUSTRALIA/NEW ZEALAND
PROJECTED ASIAN MARKET FOR ALLERGY PRESCRIPTION, GENERIC, AND OTC PRODUCTS BY REGION
TABLE 55 PROJECTED ASIA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 28 PROJECTED ASIA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
CHAPTER 7 DEVELOPMENTS IN ALLERGY TESTING AND TREATMENT
AND RECENT PATENTS
NEW DEVELOPMENTS IN DIAGNOSTIC TESTING
ALLERGEN COMPONENT-RESOLVED DIAGNOSTICS
ADVANCES IN TREATMENTS
CHINESE HERBAL MEDICINE
IMMUNOTHERAPY
ANERGIS
B CELL EPITOPE-BASED IMMUNOTHERAPY
NASAL FILTERS
PATENTS
DIAGNOSIS
U.S. Patent: 8,563,258
TREATMENT
U.S. Patent: 8,859,575
U.S. Patent: 8,859,550
U.S. Patent: 8,859,505
U.S. Patent: 8,858,974
U.S. Patent: 8,858,944
U.S. Patent: 8,853,375
U.S. Patent: 8,835,603
U.S. Patent: 8,829,005
U.S. Patent: 8,822,39
U.S. Patent: 8,815,258
U.S. Patent: 8,809,527
U.S. Patent: 8,809,524
U.S. Patent: 8,796,225
U.S. Patent: 8,795,705
U.S. Patent: 8,795,666
U.S. Patent: 8,790,643
U.S. Patent: 8,785,393
U.S. Patent: 8,778,344
U.S. Patent: 8,763,604
U.S. Patent: 8,759,403
U.S. Patent: 8,748,126
U.S. Patent: 8,747,813
U.S. Patent: 8,741,323
U.S. Patent: 8,734,783
U.S. Patent: 8,722,883
U.S. Patent: 8,703,144
U.S. Patent: 8,697,869
U.S. Patent: 8,697,083
U.S. Patent: 8,664,215
U.S. Patent: 8,663,695
U.S. Patent: 8,658,637
U.S. Patent: 8,658,630
U.S. Patent: 8,637,037
U.S. Patent: 8,632,775
U.S. Patent: 8,628,946
U.S. Patent: 8,592,381
U.S. Patent: 8,591,907
U.S. Patent: 8,580,829
U.S. Patent: 8,575,181
U.S. Patent: 8,575,165
U.S. Patent: 8,575,158
U.S. Patent: 8,574,630
U.S. Patent: 8,574,564
CHAPTER 8 COMPANY PROFILES
DIAGNOSTICS
ALERE
ALK-ABELLO A/S
ALLERGY LABORATORIES INC.
ALLERGOPHARMA AG
ANI BIOTECH OY
BECKMAN COULTER/DANAHER
BIOMERICA
DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
FIRST DIAGNOSTIC LLC
GREER HUMAN ALLERGY
HAL ALLERGY
HOLLISTER-STIER ALLERGY
HITACHI CHEMICAL DIAGNOSTICS INC.
HYCOR BIOMEDICAL
LABCORP OF AMERICA
LINCOLN DIAGNOSTICS
QUEST DIAGNOSTICS
SIEMENS HEALTHCARE
SMARTPRACTICE DENMARK
TERUMO MEDICAL PRODUCTS
THERMO FISHER DIAGNOSTICS (IMMUNODIAGNOSTICS)
TREATMENTS
ALCON LABORATORIES
ALK-ABELLO A/S
ALLERGEN PHARMACEUTICALS
AMEDRA PHARMACEUTICALS LLC
AQUA PHARMACEUTICALS
FERNDALE PHARMA GROUP (FERNDALE HEALTHCARE)
GLADERMA S.A.
GLAXOSMITHKLINE
JOHNSON & JOHNSON
KYOWA HAKKO KIRIN PHARMA INC.
LUPIN LTD.
MEDA AB
MERCK
MYLAN INC.
PFIZER
PIERRE FABRE MEDICAMENT
RANBAXY LABORATORIES
ROCHE
SANDOZ INTERNATIONAL GMBH
SANOFI
STALLERGENES AS
TARO PHARMACEUTICAL INDUSTRIES
UCB PHARMA LTD.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report